tp53-dependent G2 arrest mediator candidate gene, Reprimo, is down-regulated by promoter hypermethylation in pediatric acute myeloid leukemia

References

• Appelbaum FR, Baer MR, Carabasi MH, et al. NCCN Practice Guidelines for Acute Myelogenous Leukemia. Oncology (Williston Park) 2000;14:53–61.
   PubMed Web of Science ®Google Scholar
• Sanz GF, Sanz MA, Vallespi T, et al. Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients. Blood 1989;74:395–408.
   PubMed Web of Science ®Google Scholar
• Mann MR, Bartolomei MS. Epigenetic reprogramming in the mammalian embryo: struggle of the clones. Genome Biol 2002; 3: REVIEWS1003.
   Web of Science ®Google Scholar
• Claus R, Hackanson B, Poetsch AR, et al. Quantitative analyses of DAPK1 methylation in AML and MDS. Int J Cancer 2012;131: E138–E142.
   PubMed Web of Science ®Google Scholar
• Voso MT, Scardocci A, Guidi F, et al. Aberrant methylation of DAP-kinase in therapy-related acute myeloid leukemia and myelodysplastic syndromes. Blood 2004;103:698–700.
   PubMed Web of Science ®Google Scholar
• Griffiths EA, Gore SD, Hooker CM, et al. Epigenetic differences in cytogenetically normal versus abnormal acute myeloid leukemia. Epigenetics 2010;5:590–600.
   PubMed Web of Science ®Google Scholar
• Brakensiek K, Langer F, Schlegelberger B, et al. Hypermethylation of the suppressor of cytokine signalling-1 (SOCS-1) in myelodysplastic syndrome. Br J Haematol 2005;130:209–217.
   PubMed Web of Science ®Google Scholar
• Chen CY, Tsay W, Tang JL, et al. SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia. Genes Chromosomes Cancer 2003;37:300–305.
   PubMed Web of Science ®Google Scholar
• Preisler HD, Li B, Chen H, et al. P15INK4B gene methylation and expression in normal, myelodysplastic, and acute myelogenous leukemia cells and in the marrow cells of cured lymphoma patients. Leukemia 2001;15:1589–1595.
   PubMed Web of Science ®Google Scholar
• Tschan MP, Vonlanthen S, Cajot JF, et al. Different p16INK4a and p14ARF expression patterns in acute myeloid leukaemia and normal blood leukocytes. Leuk Lymphoma 2001;42:1077–1087.
   PubMed Web of Science ®Google Scholar
• Ekmekci CG, Gutierrez MI, Siraj AK, et al. Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia. Am J Hematol 2004;77:233–240.
   PubMed Web of Science ®Google Scholar
• Hackanson B, Daskalakis M. Decitabine. Recent Results Cancer Res 2014;201:269–297.
   PubMedGoogle Scholar
• Momparler RL, Cote S, Momparler LF. Epigenetic action of decitabine (5-aza-2’-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C). Leuk Res 2013;37:980–984.
   PubMed Web of Science ®Google Scholar
• Khan C, Pathe N, Fazal S, et al. Azacitidine in the management of patients with myelodysplastic syndromes. Ther Adv Hematol 2012;3:355–373.
   PubMedGoogle Scholar
• Ohki R, Nemoto J, Murasawa H, et al. Reprimo, a new candidate mediator of the p53-mediated cell cycle arrest at the G2 phase. J Biol Chem 2000;275:22627–22630.
   PubMed Web of Science ®Google Scholar
• Taylor WR, Stark GR. Regulation of the G2/M transition by p53. Oncogene 2001;20:1803–1815.
   PubMed Web of Science ®Google Scholar
• Otsuka T, Kohno T, Mori M, et al. Deletion mapping of chromosome 2 in human lung carcinoma. Genes Chromosomes Cancer 1996;16:113–119.
   PubMed Web of Science ®Google Scholar
• Olaru A, Mori Y, Yin J, et al. Loss of heterozygosity and mutational analyses of the ACTRII gene locus in human colorectal tumors. Lab Invest 2003;83:1867–1871.
   PubMed Web of Science ®Google Scholar
• Piao Z, Lee KS, Kim H, et al. Identification of novel deletion regions on chromosome arms 2q and 6p in breast carcinomas by amplotype analysis. Genes Chromosomes Cancer 2001;30:113–122.
   PubMed Web of Science ®Google Scholar
• Xu M, Knox AJ, Michaelis KA, et al. Reprimo (RPRM) is a novel tumor suppressor in pituitary tumors and regulates survival, proliferation, and tumorigenicity. Endocrinology 2012;153:2963–2973.
   PubMed Web of Science ®Google Scholar
• Bernal C, Aguayo F, Villarroel C, et al. Reprimo as a potential biomarker for early detection in gastric cancer. Clin Cancer Res 2008;14:6264–6269.
   PubMed Web of Science ®Google Scholar
• Beasley WD, Beynon J, Jenkins GJ, et al. Reprimo 824 G> C and p53R2 4696 C> G single nucleotide polymorphisms and colorectal cancer: a case-control disease association study. Int J Colorectal Dis 2008;23:375–381.
   PubMed Web of Science ®Google Scholar
• Ooki A, Yamashita K, Yamaguchi K, et al. DNA damage-inducible gene, reprimo functions as a tumor suppressor and is suppressed by promoter methylation in gastric cancer. Mol Cancer Res 2013;11: 1362–1374.
   PubMed Web of Science ®Google Scholar
• Luo J, Zhu Y, Yang G, et al. Loss of Reprimo and S100A2 expression in human gastric adenocarcinoma. Diagn Cytopathol 2011;39: 752–757.
   PubMed Web of Science ®Google Scholar
• Morris MR, Ricketts C, Gentle D, et al. Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma. Oncogene 2010;29:2104–2117.
   PubMed Web of Science ®Google Scholar
• Murphy TM, Perry AS, Lawler M. The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer. Endocr Relat Cancer 2008;15:11–25.
   PubMed Web of Science ®Google Scholar
• Ellinger J, Bastian PJ, Jurgan T, et al. CpG island hypermethylation at multiple gene sites in diagnosis and prognosis of prostate cancer. Urology 2008;71:161–167.
   PubMed Web of Science ®Google Scholar
• Ellinger J, Haan K, Heukamp LC, et al. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer. Prostate 2008;68:42–49.
   PubMed Web of Science ®Google Scholar
• Yu J, Zhu T, Wang Z, et al. A novel set of DNA methylation markers in urine sediments for sensitive/specific detection of bladder cancer. Clin Cancer Res 2007;13:7296–7304.
   PubMed Web of Science ®Google Scholar
• Sato N, Fukushima N, Matsubayashi H, et al. Aberrant methylation of Reprimo correlates with genetic instability and predicts poor prognosis in pancreatic ductal adenocarcinoma. Cancer 2006;107: 251–257.
   PubMed Web of Science ®Google Scholar
• Hamilton JP, Sato F, Jin Z, et al. Reprimo methylation is a potential biomarker of Barrett’s-Associated esophageal neoplastic progression. Clin Cancer Res 2006;12:6637–6642.
   PubMed Web of Science ®Google Scholar
• Takahashi T, Suzuki M, Shigematsu H, et al. Aberrant methylation of Reprimo in human malignancies. Int J Cancer 2005; 115:503–510.
   PubMed Web of Science ®Google Scholar
• Inaba T.[Epidemiology of leukemia and MDS among atomic bomb survivors in Hiroshima and Nagasaki suggests how abnormal epigenetic regulation contributes to leukemogenesis]. Rinsho Ketsueki 2009;50:1548–1552.
   PubMedGoogle Scholar
• Olek A, Oswald J, Walter J. A modified and improved method for bisulphite based cytosine methylation analysis. Nucleic Acids Res 1996;24:5064–5066.
   PubMed Web of Science ®Google Scholar
• Yan-Fang T, Jian N, Jun L, et al. The promoter of miR-663 is hypermethylated in Chinese pediatric acute myeloid leukemia (AML). BMC Med Genet 2013;14:74.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Geng H, Cheng SH, et al. KRAB zinc finger protein ZNF382 is a proapoptotic tumor suppressor that represses multiple oncogenes and is commonly silenced in multiple carcinomas. Cancer Res 2010;70:6516–6526.
   PubMed Web of Science ®Google Scholar
• Tao YF, Xu LX, Lu J, et al. Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation. J Transl Med 2014;12:182.
   PubMed Web of Science ®Google Scholar
• Jian P, Li ZW, Fang TY, et al. Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663. J Hematol Oncol 2011;4:20.
   PubMed Web of Science ®Google Scholar
• Yan-Fang T, Dong W, Li P, et al. Analyzing the gene expression profile of pediatric acute myeloid leukemia with real-time PCR arrays. Cancer Cell Int 2012;12:40.
   PubMed Web of Science ®Google Scholar
• Tao YF, Lu J, Du XJ, et al. Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells. BMC Cancer 2012;12:619.
   PubMed Web of Science ®Google Scholar
• Inbal B, Shani G, Cohen O, et al. Death-associated protein kinase-related protein 1, a novel serine/threonine kinase involved in apoptosis. Mol Cell Biol 2000;20:1044–1054.
   PubMed Web of Science ®Google Scholar
• Wu M, Xu LG, Li X, et al. AMID, an apoptosis-inducing factor-homologous mitochondrion-associated protein, induces caspase-independent apoptosis. J Biol Chem 2002;277:25617–25623.
   PubMed Web of Science ®Google Scholar
• Marshall KR, Gong M, Wodke L, et al. The human apoptosis-inducing protein AMID is an oxidoreductase with a modified flavin cofactor and DNA binding activity. J Biol Chem 2005;280:30735–30740.
   PubMed Web of Science ®Google Scholar
• Zhu YJ, Xu B, Xia W. Hsa-mir-182 downregulates RASA1 and suppresses lung squamous cell carcinoma cell proliferation. Clin Lab 2014;60:155–159.
   PubMed Web of Science ®Google Scholar
• Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 1988;335:440–442.
   PubMed Web of Science ®Google Scholar
• Okamoto T, Coultas L, Metcalf D, et al. Enhanced stability of Mcl1, a prosurvival Bcl2 relative, blunts stress-induced apoptosis, causes male sterility, and promotes tumorigenesis. Proc Natl Acad Sci USA 2014;111:261–266.
   PubMed Web of Science ®Google Scholar
• Kozopas KM, Yang T, Buchan HL, et al. MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2. Proc Natl Acad Sci USA 1993;90:3516–3520.
   PubMed Web of Science ®Google Scholar